MoneyWorks4Me

Bharat Parenterals informs about outcome of board meeting

11 Feb 2021 Evaluate

In compliance of Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Bharat Parenterals has informed that the Board of Directors of the Company in its meeting held on 11th February, 2021, has considered and approved the Unaudited Financial Results for the Quarter ended 31st December, 2020 and taken on record Limited Review Report issued by the Statutory Auditors of the Company. In this respect, the company has enclosed the Unaudited Financial Results for the Quarter ended 31st December, 2020 and limited Review Report on the said Financial Results. The meeting of Board of Directors commenced at 01.00 pm and concluded at 02:00 pm.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..